3-(Tributylstannyl)pyridine → HCID 57634255, 화합물
반응식
Br[C:2]1[S:6][C:5]([N:7]2[CH2:11][C:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[N:4][CH:3]=1.C([Sn](CCCC)(CCCC)[C:25]1[CH:26]=[N:27][CH:28]=[CH:29][CH:30]=1)CCC>>[N:27]1[CH:28]=[CH:29][CH:30]=[C:25]([C:2]2[S:6][C:5]([N:7]3[CH2:11][C:10]4([CH:16]5[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]5)[CH2:12]4)[O:9][C:8]3=[O:19])=[N:4][CH:3]=2)[CH:26]=1참가 물질
3
실험 절차
The title compound was prepared by a method analogous to that described in Example 14 from 3′-(5-bromothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and 3-(tri-n-butylstannyl)pyridine. The title compound (87 mg) was obtained as a pale solid, m/z 343 (MH+).
후처리
- customThe title compound was prepared by a method analogous to
출처 및 근거
- ORD 기록
- ord-dad5550eaaf441a0bc1582d9178b130a
- 출처 데이터셋
- uspto-grants-2009_04